← Explorer/Network

Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Martin Voß, Johanna Kotrba, Evelyn Gaffal +2 more2021International Journal of Molecular SciencesReview
10.3390/ijms22094589PubMedFree full text
DermatologicalImmune/Innate
Volatile Organic Compounds (VOCs)

Abstract

Mast cells (MCs) are best-known as key effector cells of immediate-type allergic reactions that may even culminate in life-threatening anaphylactic shock syndromes. However, strategically positioned at the host-environment interfaces and equipped with a plethora of receptors, MCs also play an important role in the first-line defense against pathogens. Their main characteristic, the huge amount of preformed proinflammatory mediators embedded in secretory granules, allows for a rapid response and initiation of further immune effector cell recruitment. The same mechanism, however, may account for detrimental overshooting responses. MCs are not only detrimental in MC-driven diseases but also responsible for disease exacerbation in other inflammatory disorders. Focusing on the skin as the largest immune organ, we herein review both beneficial and detrimental functions of skin MCs, from skin barrier integrity via host defense mechanisms to MC-driven inflammatory skin disorders. Moreover, we emphasize the importance of IgE-independent pathways of MC activation and their role in sustained chronic skin inflammation and disease exacerbation.

Key Biomarkers

Immunoglobulin E (IgE)

References (2)

  • Mast cells in the development of adaptive immune responsesNature Immunology · 2005
  • Mast-cell responses to pathogensNature reviews. Immunology · 2004

Related Papers

  • What initiates chemical intolerance? Findings from a large population-based survey of U.S. adultsEnvironmental Sciences Europe · 2023 · 3 shared tags
  • The Sick Building Syndrome as a Part of the Autoimmune (Autoinflammatory) Syndrome Induced by Adjuvant2024 · 3 shared tags
  • Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor PrognosisFrontiers in Immunology · 2022 · 3 shared tags
  • Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)Pneumologie · 2024 · 3 shared tags
  • Indoor microbiome and allergic diseases: From theoretical advances to prevention strategiesEco-Environment & Health · 2022 · 3 shared tags
  • AhR signalling and dioxin toxicityToxicology Letters · 2014 · 3 shared tags